Health Risks for Medical Students on Electives Overseas

Questionnaire for Medical Schools

 

  1. Medical School, please specify

    ……………………………………………………
  2.  

  3. At which stage in the course do your students go on their electives?
  4.  

    ………………………………………………...

     

  5. How long in advance are students encouraged to start making their elective plans?
  6.  

    …………………………………………………...

     

  7. To whom do students normally go for advice regarding their elective plans?
  8.  

    …………………………………………………

     

  9. Does your School have a written policy regarding electives and blood-borne viruses?

Y/N

If yes, (a) Who produced it? …………………………………………………..

    1. Will you be or have you already changed it following the publication of the latest guidance from the UK Health Departments on HIV post-exposure prophylaxis (PEP) (July 2000)?

Y/N

If no, (c) Have you had an unwritten policy? Y/N

    1. Will you be producing a written policy following the publication of
      the latest guidance from the UK Health Departments on HIV PEP
      (July 2000)? Y/N

 

  1. Did you read our paper in the BMJ (Gamester CF, Tilzey AH, Banatvala JE. Medical students’ risk of infection with bloodborne viruses at home and abroad: questionnaire survey. BMJ 1999;318:158-60 16 January) or a paper on a similar topic in the same issue (Moss PJ, Beeching NJ. Provision of health advice for UK medical students planning to travel overseas for their elective study period: questionnaire survey. BMJ 1999;318:161-2 16 January) or the leader in the same issue (Wilkinson D, Symon B. Medical students, their electives and HIV)? [Copies of these are attached]
  2. Y/N

    If you read any/all of these, did this alter your Medical School policy on medical students and

    electives in any way?

    Y/N

    If yes, how?
    ………………………………………………………..

  3. If your medical school has more than one campus, is your policy on medical students and electives consistent across sites?
  4. Y/N

  5. Does your School restrict in any way what students can do in countries with a relatively high seroprevalence of HIV?

Y/N

If yes, (a) How do you define a relatively high seroprevalence (please circle)?

>1%

>5%

Other ……………………………………..

 

    1. What restrictions do you impose on them? Do you, for example, advise against involvement in exposure prone procedures in:

Trauma Medicine Y/N

O&G Y/N

General Surgery Y/N

Deep abdominal/pelvic/thoracic surgery Y/N

Other (please state which) ………………………………..

 

  1. Would your policy vary according to information available to you about the elective on:
  2. Levels of supervision Y/N

    Standard of Infection Control Y/N

    If yes to one or both, how?

    ………………………………………………………………………

     

  3. Does your school make a particular effort to educate and advise students on the risks and prevention of occupational infection with blood-borne viruses in the context of the elective?
  4. Y/N

    If yes, how?

    Lectures Y/N

    Written advice Y/N

    Other …………………………………………………...

     

  5. Do you advise students going on their electives to countries with a relatively high prevalence of HIV to:
  6. (a) Take starter packs of HIV PEP Y/N

    If yes, what? (circle one) Just AZT

    Combivir

    Triple Therapy

    If yes, do the students have to pay for the starter packs? Y/N

    If no, who does pay? ……………………..……………………………………………….

     

    (b) Take a supply of latex gloves Y/N

    (c) Have a dental check up before departure Y/N

     

    (d) Take a ‘medikit’ Y/N

     

    (e) Check their blood group Y/N

     

    (f) Take a plasma expander Y/N

     

  7. If a student has a percutaneous or mucosal exposure on elective putting them at risk of infection with a blood borne virus, who would they contact in your Medical School/Hospital?
  8. …………………………………………………...

  9. Does your School provide written advice on vaccinations for electives? Y/N
  10. If yes, who produces this? …………………………………………………...

  11. Does your School provide a vaccination service for students going on electives? Y/N
  12. If yes, who provides this? …………………………………………………...

     

  13. Does your School provide anti-malarial advice for students going on electives?
  14. Y/N

    If yes, who provides this?

    ………………………………………………….

  15. During the last 3 years, have any students, whilst on elective:
  16. (a) Died Y/N

    If yes, how many and how? ……………………………………………………………..

     

    (b) Acquired malaria Y/N

    If yes, how many? ……………………………………………………………..

    If yes, had they taken antimalarial prophylaxis? Y/N

     

    (c) Acquired Dengue Y/N

    If yes, how many? ……………………………………………………………..

     

    (d) Acquired Dysentery Y/N

    If yes, how many? ……………………………………………………………..

     

    (e) Other acquired dangerous infections …………………………………………………..

    If yes, how many? ………………………………………………….

     

    (f) Had accidents

    Road Traffic Accident Y/N

    If yes, how many? …………………………………………………...

     

    Assault Y/N

    If yes, how many? …………………………………………………...

     

     

    Other (please specify) ……………………………………………………

     

    If yes, how many? ..………………………………………………….

  17. Any further comments, please add below

……………………………………………………………………………………………………………

……………………………………………………………………………………………………………

……………………………………………………………………………………………………………

……………………………………………………………………………………………………………

 

Please return this questionnaire when completed by post to:

Mr Michael Powell
Executive Officer
Council of Heads of Medical Schools
Woburn House
20 Tavistock Square
LONDON
WC1H 9HD

Or by fax to 020 7380 1482

If you would like it emailed to you or have other queries, please contact CHMS on 020 7419 5494.